A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer

Background: Patients with triple-negative breast cancer (TNBC) face a major challenge of the poor prognosis, and N6-methyladenosine-(m6A) mediated regulation in cancer has been proposed. Therefore, this study aimed to explore the prognostic roles of m6A-related long non-coding RNAs (LncRNAs) in TNBC...

Full description

Bibliographic Details
Main Authors:	Cai, Y. (Author), Li, M. (Author), Wu, J. (Author), Zhao, G. (Author)
Format:	Article
Language:	English
Published:	John Wiley and Sons Inc 2021
Subjects:	6 n methyladenosine adenosine Adenosine adult Adult aged Aged ANKRD10 IT1 gene Article biological model Biomarkers, Tumor BLACAT1 gene BVES AS1 gene cancer prognosis cell communication ceRNA network CIRBP AS1 gene comparative study competing endogenous RNA controlled study female Female gene expression gene expression regulation Gene Expression Regulation, Neoplastic gene regulatory network Gene Regulatory Networks gene targeting genetics HOXB AS1 gene human human cell human tissue Humans Kaplan Meier method Kaplan-Meier Estimate LINC00571 gene LINC00593 gene long non-coding RNA long untranslated RNA major clinical study medical information messenger RNA middle aged Middle Aged MIR205HG gene Models, Genetic mortality N6-methyladenosine N-methyladenosine oncogene overall survival pathogenesis prediction prognosis Prognosis prognostic signature receiver operating characteristic RNA RNA, Long Noncoding ROC Curve SAMD12 AS1 gene signal transduction SUCLG2 AS1 gene triple negative breast cancer Triple Negative Breast Neoplasms triple-negative breast cancer tumor marker unclassified drug
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer

Internet

Similar Items